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Abstract
Vinpocetine is considered as neuroprotectant drug and used for treatment of brain ischemia and cognitive deficiencies for 
decades. A number of enzymes, channels and receptors can bind vinpocetine, however the mechanisms of many effects’ 
are still not clear. The present study investigated the effects of vinpocetine from the mitochondrial bioenergetic aspects. In 
primary brain capillary endothelial cells the purinergic receptor-stimulated mitochondrial  Ca2+ uptake and efflux were stud-
ied. Vinpocetine exerted a partial inhibition on the mitochondrial calcium efflux. In rodent brain synaptosomes vinpocetine 
(30 μM) inhibited respiration in uncoupler stimulated synaptosomes and decreased  H2O2 release from the nerve terminals 
in resting and in complex I inhibited conditions, respectively. In isolated rat brain mitochondria using either complex I or 
complex II substrates leak respiration was stimulated, but ADP-induced respiration was inhibited by vinpocetine. The stimu-
lation of oxidation was associated with a small extent of membrane depolarization. Mitochondrial  H2O2 production was 
inhibited by vinpocetine under all conditions investigated. The most pronounced effects were detected with the complex II 
substrate succinate. Vinpocetine also mitigated both  Ca2+-induced mitochondrial  Ca2+-release and  Ca2+-induced mitochon-
drial swelling. It lowered the rate of mitochondrial ATP synthesis, while increasing ATPase activity. These results indicate 
more than a single mitochondrial target of this vinca alkaloid. The relevance of the affected mitochondrial mechanisms in 
the anti ischemic effect of vinpocetine is discussed.
Keywords Vinpocetine · Neuroprotection · Mitochondria · Reactive oxygen species · Calcium induced calcium release · 
Oxygen consumption · ATP synthesis · Uncoupling
Introduction
Vinpocetine has been marketed for more than 30 years. 
Among its indication are ischemic neuronal damage [1], 
stroke [2, 3], cerebrovascular diseases [4], neurodegenerative 
diseases [5, 6], dementia and cognitive deficits [1, 7]. During 
this period many targets and mechanisms of actions has been 
proposed, including the inhibition of the cyclic nucleotide 
phosphodiesterase 1 (PDE1) [8, 9], voltage-dependent  Na+ 
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channels [10, 11], the IκB kinase, the NF-κB [12] and bind-
ing to peripheral benzodiazepine receptors [13]. For a recent 
review see [14]. As a consequence of having numerous tar-
gets, the drug can influence diverse functions. The present 
study focuses on the effects of vinpocetine on mitochondrial 
function. The brain is extremely sensitive to proper provision 
of energy, in which mitochodria play a central role. Most of 
the inborn errors of metabolism are associated with struc-
tural and/or functional brain damage and mental retarda-
tion. Mitochondria are not only cellular power stations, but 
also pollute their environment with reactive oxygen species 
(ROS). Although as a consequence of powerful antioxidant 
systems most of the mitochondrially produced ROS will 
not leave the mitochondria in physiological conditions [15], 
excessive mitochondrial ROS generation is considered as 
an important factor in cerebral ischemia/reperfusion injury 
[16–19], neurodegeneration [20] and glutamate toxicity [21, 
22]. Early studies already addressed mitochondria as poten-
tial vinpocetine targets, but only in a very few studies were 
mitochondria the focus of the investigation. Vinpocetine’s 
effect has been explained by binding to the peripheral ben-
zodiazepine receptor [22], a mitochondrial outer membrane 
protein and putative component of the mitochondrial perme-
ability transition pore (PTP). In the present study the effects 
of vinpocetine are investigated at three level of complexity, 
in cellular systems (primary neuronal and endothelial cell 
cultures), in isolated nerve terminals (synaptosomes) and in 
isolated guinea pig brain mitochondria. Complex biological 
phenomena like delayed calcium deregulation, intracellular 
calcium transients and  Ca2+ release from in situ mitochon-
dria have been investigated in cellular systems, while mito-
chondrial oxygen consumption, ROS production, ATPase 
activity in isolated mitochondria. We conclude that the 
delayed PTP opening, mild mitochondrial depolarization and 
decreased  H2O2 release may all play an important role in the 
beneficial effects of vinpocetine in pathological conditions 
associated with neuronal damage.
Materials and Methods
Animals
For cell culture and synaptosomal experiments Wistar rats 
were used. Mitochondria were isolated from guinea pig 
brain. Animal experiments were performed in accordance 
with the Guidelines for Animal Experiments at Semmelweis 
University.
Cell Cultures
Brain capillary endothelial cells from 3 to 5 month-old 
Wistar rats were prepared and seeded on extracellular 
matrix coated glass coverslips as described earlier [23]. Cul-
tures were kept in DMEM containing 17% plasma-derived 
bovine serum (First Link, UK), supplemented with 2 mM 
glutamine, 80 µg/ml heparin, 150 µg/ml endothelial cell 
growth supplement (Sigma), antibiotics, and trace factors 
(vitamin C, selenium, insulin, transferrin and glutathione). 
After reaching confluence, experiments were performed on 
6–10 days old primary cultures.
Primary neuron-enriched cultures were prepared from 
E17 Wistar rat embryos, plated on 6 mm glass coverslips 
coated with poly-l-ornithine plus laminin in 12-well plates 
or on Petri dishes coated with poly-d-lysine, and maintained 
in Neurobasal medium (Invitrogen, Carlsbad, CA) with 
2% B27 supplement (Invitrogen) and 2 mM glutamine for 
8–12 days at 37 °C, 5%  CO2 without feeding [24].
Measurements of Mitochondrial Calcium Transients
In situ mitochondrial and cytoplasmic calcium measure-
ments were performed in brain capillary endothelial cell 
cultures (at 7–8 days in vitro) by X-Rhod-1-AM (Molecular 
Probes, Eugene, OR, USA), localized mainly in mitochon-
dria, a calcium sensitive dye with fluorescence microscopy 
as described earlier [25]. Briefly, mitochondrial calcium 
transients  ([Ca2+]m) were analyzed using highpass spatial 
filtering of fluorescence images using the “the original 
X-rhod-1 mito filter.flt” in Image Analyst MKII (Image 
Analyst Software, Novato, CA, USA). Cytosolic calcium 
transients  ([Ca2+]c) were analyzed on the same images left 
unfiltered by the measurement of X-Rhod-1 fluorescence of 
the nuclear region in the cell [25]. Half decay time (τ1/2) was 
defined as the time between peak of the transient and the 
intensity decaying to half of the peak amplitude.
Fluorimetric measurements were performed to examine 
potential optical or chemical interaction of vinpocetine and 
calcium sensitive fluorescent dyes (X-Rhod-1 and Fura-FF), 
to exclude the possibility of recording artefacts due to the 
change in fluorescence. Fluorescence of vinpocetine in aque-
ous solution was negligible both in the range of Fura-FF 
emission 510 nm (excitation: 340/380 nm) and in the range 
of X-Rhod-1 emission 570 nm (excitation: 535 nm). 30 μM 
vinpocetine had no effect on the fluorescence of hydrolyzed 
X-Rhod-1 or Fura-FF dyes either in high calcium (40 μM) 
containing or in calcium free intracellular solution (pH 7.4, 
37 °C).
Measurement of Delayed  Ca2+ Deregulation 
in Isolated Primary Rat Brain Neurons
Time-lapse fluorescence microscopy of rat primary corti-
cal cultures was carried out using the above fluorescence 
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microscope setup using a UAPO 20 × dry 0.75 NA lens. Cul-
tures were incubated with Fura-FF-AM (3 µM) for 15 min 
at 37 °C and subsequently rinsed with superfusion medium. 
Fura-FF fluorescence was ratio imaged using 340/10 (center/
bandwidth in nm) and 380/10 exciters (Chroma, Rocking-
ham, VT, USA), a 400DCLP dichroic mirror and a 470LP 
long pass emitter (Omega Optical, Brattleboro, VT, USA) 
[24].
Isolation of Synaptosomes from Rat Brain
Synaptosomes were isolated from rat brain cortex as 
described earlier [26]. The synaptosomal fraction was 
obtained after sucrose (0.8 M)  gradient centrifugation. 
Sucrose was diluted by ice cold distilled water to 0.32 M and 
synaptosomes were sedimented with 20,000×g for 20 min. 
The pellet’s protein concentration was adjusted to about 
20 mg/ml, and synaptosomes were kept on ice until use.
Most of the experiments were performed in standard 
extracellular medium composed of (mM): 140 NaCl, 3 
KCl, 2  MgCl2, 2  CaCl2, 10 PIPES pH 7.38 and 10 glucose. 
Incubations and measurements were done at 37 °C. Synap-
tosomes retained their basic bioenergetic parameters for at 
least 6 h.
Isolation of Rodent Brain Mitochondria
Guinea pig mitochondria were isolated using discontinu-
ous percoll gradient as described [27]. Mitochondria were 
incubated in the following incubation buffer (mM): 125 
KCl, 20 HEPES, 2  K2HPO4, 1  MgCl2, 0.1 EGTA, at pH 7.0 
adjusted by KOH. Incubation buffer was supplemented with 
0.025 w/v % fatty acid free BSA. To use BSA was necessary, 
because mitochondria may lose their functional parameters 
very quickly as a consequence of liberated fatty acids [28].
Oxygen Consumption 
of Synaptosomes and Mitochondria
Oxygen consumption of synaptosomes were measured 
by high resolution respirometry Oxygraph-2K (Oroboros 
Instruments, Innsbruck, Austria) [29] at 37  °C in 2-ml 
chambers. Data were digitally recorded and analyzed; oxy-
gen flux was calculated as the negative temporal derivative 
of the oxygen concentration, cO2(t). Oxygen sensors were 
calibrated routinely in air saturated and oxygen depleted 
media. Synaptosomal protein concentration was 2 mg/ml, 
mitochondrial protein concentration was 0.1 mg/ml.
Measurement of Mitochondrial Membrane Potential 
(Δψm)
Mitochondrial membrane potential was measured by a cus-
tom-made tetraphenylphosphorium  (TPP+) electrode [30]. 
 TPP+ is a lipophilic membrane permeable cation. With 
the TPP+ electrode the extramitochondrial concentration 
of  TPP+ was measured as described earlier. Knowing the 
total concentration of the  TPP+ Δψm was calculated using 
the Nernst equation.
Measurement of  H2O2 Production in Mitochondria 
and in Synaptosomes
H2O2 released from mitochondria was detected with horse-
radish peroxidase (5U/2 ml) and Amplex Ultrared (3 μM) 
[31]. As a result of peroxidase action Amplex Ultrared was 
converted to fluorescent resorufin in the presence of mito-
chondria (0.1 mg/ml), and measured using PTI Deltascan 
fluorescence spectrophotometer (550 nm excitation, 585 nm 
emission wavelengths; Photon Technology International, 
Lawrenceville, NJ, USA). Each measurement was calibrated 
with known amounts of  H2O2 at the end of the experiment.
Measurement of Mitochondrial  Ca2+ Uptake
Mitochondria (0.05 mg/ml) were incubated in the follow-
ing reaction medium (mM): 8 KCl, 110 K-gluconate, 10 
NaCl, 10 HEPES, 2  KH2PO4, 4  MgCl2, 10 mannitol, 5 glu-
tamate, 5 malate, 3 ATP, 0.25 ADP pH 7.25 (KOH) sup-
plemented with 0.025% BSA. The free  Ca2+ concentration 
was calculated with the WinMAXC software ([32, 33].  Ca2+ 
 (CaCl2) was given to mitochondria in the form of 12.5 μM 
 Ca2+ pulses. The  Ca2+ level of the medium was followed 
by Calcium-Green 5 N  (KD = 4.29 μM). Wavelengths for 
Calcium-green fluorescence were 505 nm excitation and 
535 nm emission, respectively.
Measurement of Mitochondrial Swelling
Swelling of isolated mitochondria can reflect permeability 
pore opening (see [33, 34]) and was followed by light scat-
tering at 590 nm in parallel with mitochondrial  Ca2+ uptake 
using double excitation, double emission mode of PTI Del-
tascan spectrofluorimeter. At the end of each measurement 
alamethicin (a pore forming peptide 80 μg/2 ml) was added 
to obtain maximal swelling.
Kinetic measurement of Mitochondrial ATP 
Synthesis
Mitochondrial ATP formation was monitored by a com-
bined enzymatic system comprising of hexokinase and 
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glucose-6-phosphate dehydrogenase, as described ear-
lier [35, 36]. Mitochondria (0.05 mg/ml) were incubated 
in the medium described in the isolation procedure. 
This medium was supplemented with 3  mM  NADP+, 
1.5 U hexokinase, 0.5 U glucose-6-phosphate dehydro-
genase, 5 mM glucose, 2 mM ADP and 200 µM AP5 
 (P1,P5-Di(adenosine-5′) pentaphosphate), an inhibitor of 
adenylate kinase) in 2 ml total volume (Melnick et al. 
1979). In the presence of mitochondria, ADP and respira-
tory substrates glutamate plus malate ATP was formed, 
which mostly left the mitochondria via the adenine 
nucleotide translocase. ATP phosphorylated glucose (to 
glucose-6-phosphate) by hexokinase. The resulted prod-
uct glucose-6-phosphate was oxidized to 6-phosphogluco-
nate by glucose-6-phospate dehydrogenase with the con-
comitant reduction of  NADP+ to NADPH. Thus, NADPH 
formation was stoichiometrically equal to ATP released 
from the mitochondria. The  absorbance of NADPH 
(ɛ = 6220 M−1  cm−1) was recorded at 340 nm, 37 °C using 
a JASCO V-650 spectrophotometer (ABL&E-JASCO, 
Tokyo, Japan). ATP standards were used for calibration.
Measurement of ATPase Activity
ATP hydrolyzed by mitochondria in the absence of res-
piratory substrates was measured by a combined enzyme 
assay [37]. The standard assay medium was supplemented 
with NADH (300 μM), lactate dehydrogenase (2 U/ml), 
pyruvate kinase (PK; 2 U/ml), phosphoenolpyruvate 
(PEP; 2 mM), ATP (0.5 mM), and rotenone (1 μM). In the 
medium, ADP was phosphorylated to ATP in the presence 
of PK and PEP, then pyruvate was reduced to lactate with 
the concomitant oxidation of NADH to  NAD+. Absorb-
ance of NADH was monitored at 340 nm using a JASCO 
spectrophotometer. Measurements were calibrated with 
known amounts of ADP.
Statistics
Statistical differences were evaluated with ANOVA in Sig-
mastat wherever multiple comparisons were made. Values 
are indicated as mean ± standard error, p < 0.05 were con-
sidered statistically significant.
Results
In Situ Mitochondrial  Ca2+ Measurements 
in Brain Capillary Endothelial Cells
Brain capillary endothelial cells in primary culture were 
stimulated by the application of 100 μM ATP (Fig. 1). 
ATP triggers a transient rise of cytoplasmic  [Ca2+] 
 ([Ca2+]c,  Fig.  1b) and mitochondrial  [Ca2+]  ([Ca2+]m, 
Fig. 1a) by activating purinergic receptors and IP3-mediated 
 Ca2+ release from the endoplasmic reticulum [23]. Mito-
chondria take up  Ca2+ from the cytoplasm by the calcium 
Fig. 1  Mitochondrial (a) and cytosolic (b) calcium transients of pri-
mary brain  capillary endothelial cells stimulated by the addition of 
100 μM ATP. ATP was provided by superfusion at the indicated time. 
Mitochondrial and cytosolic Ca2+ transients were extracted from the 
same recordings  using image processing. Pooled from 3 measure-
ments, total cell number: 17
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uniporter any  Ca2+ is predominantly released from mito-
chondria by the  Na+/Ca2+ exchanger.
In the stimulation paradigm depicted in Fig. 1, any change 
to  Ca2+ ‘handling’ in mitochondria is indicated by the altera-
tion of the peak amplitude or the half decay time of the 
mitochondrial  Ca2+ transient. Alteration of the peak ampli-
tude indicates changes both in the calcium influx and efflux 
while alteration of half decay time indicates change in the 
calcium efflux.
Effect of Vinpocetine on ATP Induced  [Ca2+]m 
and  [Ca2+]c Transients
Vinpocetine up to 10 μM had no significant effects on 
the parameters of  [Ca2+]m, or  [Ca2+]c transients (not 
shown). However, 30 μM vinpocetine pretreatment sig-
nificantly increased half decay time of the mitochondrial 
calcium transient (from  τ1/2 = 23.5 ± 6.8 s  to  42 ± 6.2 
s, p < 0.05), but peak amplitude was not changed (from 
ampitude 2.24 ± 0.48 to 2.22 ± 0.77; given as relative fluo-
rescence change from baseline, ΔF/F0) (Fig. 2).
Parameters of the cytosolic calcium transients were not 
significantly different (from τ1/2 = 33.3 ± 5.2 s to τ1/2 = 29 
± 8.69 s and from ampitude 1.33 ± 0.13 to 1.53 ± 0.15). 
Figure not shown.
The Effect of Vinpocetine on Delayed  Ca2+ 
Deregulation (DCD)
DCD is a model of glutamate toxicity, where excessive 
calcium load through  Ca2+ permeable glutamate receptors 
could result in deterioration of calcium and energy homeo-
stasis and eventually lead to cell death [38]. Primary cor-
tical neurons were stimulated with glutamate (300 μM) 
plus glycine (10 μM) for 20 min in  Mg2+-free solution 
and cytoplasmic  [Ca2+] was measured using a low affinity 
calcium-sensitive fluorescent dye Fura-FF in single cells.
The glutamate-induced initial  Ca2+ peak was followed by 
a transient plateau where the cytosolic  [Ca2+] remained 
lower than the peak, but higher than before the stimulation. 
The length of this period had large cell to cell variations 
Fig. 2  Effect of Vinpocetine (30 μM) pretreatment on the mitochon-
drial calcium transient. Data are expressed as  mean ± SE of n = 3 
experiments; ctrl, untreated control in matched culture preparations
Fig. 3  Delayed  Ca2+ deregulation in primary cortical neurons in the 
absence (a) or presence (b) of vinpocetine (30 μM). Glutamate plus 
glycine (Glu + Gly) (a, b) and vinpocetine (vinpo) (b) were applied as 
indicated. The Fura-FF fluorescence excitation ratio reflects the cyto-
solic  Ca2+ levels. Representative traces are shown
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and was followed by a sharp, irreversible elevation of 
 [Ca2+]c termed as DCD (Fig. 3a). Vinpocetine pretreat-
ment (Fig. 3b) was unable to protect cells against DCD. 
There was neither a change in the mean time of DCD, nor 
in the fraction of cells exhibiting DCD within the time-
frame of the experiment (20 min).
The Effects of Vinpocetine on Synaptosomal Oxygen 
Consumption
Oxygen consumption of synaptosomes reflects substrate oxi-
dation by in situ synaptosomal mitochondria, whereas con-
taminating, free mitochondria are assumed to be damaged 
and metabolically silent in the presence of mM extracellular 
 Ca2+. Vinpocetine inhibited both resting and uncoupler-stim-
ulated respiration of nerve endings. energized by glucose 
(Fig. 4). Replacing glucose by lactate resulted in similar 
results (data not shown).
Effects of Vinpocetine on Synaptosomal  H2O2 
Production
In synaptosomes, ROS production can primarily be attrib-
uted to mitochondria. To address the effects of vinpocetine 
on ROS generation, cortical synaptosomes supplied with 
glucose were preincubated with vinpocetine (10 or 30 μM) 
for 5 min. Vinpocetine lowered  H2O2 release by 22%. In the 
presence of the complex I inhibitor rotenone-vinpocetine also 
significantly decreased  H2O2 production by 19.7% (Fig. 5).
Effects of Vinpocetine on Mitochondrial Membrane 
Potential
In isolated guinea pig brain mitochondria Δψm was meas-
ured with  TPP+-electrode. Mitochondria were energized 
either by glutamate plus malate or succinate. After the 
development of Δψm vinpocetine (30 μM) was given. Vin-
pocetine decreased Δψm in glutamate plus malate sup-
ported mitochondria by 4.0 ± 0.6 mV. In succinate sup-
ported mitochondria similar depolarization was detected 
(data not shown).
Effects of Vinpocetine on the Respiration of Isolated 
Guinea Pig Brain Mitochondria
Isolated mitochondria are intact cellular organelles with 
complex bioenergetic functions, e.g. membrane potential, 
ATP synthesis and  Ca2+ transport. Brain mitochondria 
were supported with complex I (glutamate plus malate) 
or complex II (succinate) substrates. Adding vinpocetine 
during resting respiration (state 2, substrate only) stimu-
lated oxygen consumption. In contrast in the presence of 
ADP (state 3 respiration) the rate of oxygen consumption 
was decreased by vinpocetine irrespective of the substrates 
applied (Fig. 6). Similarly, if vinpocetine was added after 
ADP, there was an immediate decrease in the respiration rate 
Fig. 4  The effect of vinpocetine on the  O2 consumption of syn-
aptosomes. Synaptosomes were preincubated in glucose contain-
ing standard medium for 5  min under control conditions  (C, white 
bars), or in the presence of vinpocetine (V, grey bars, 10 or 30 μM). 
First basal respiration (C baseline, V10 baseline, V30 baseline) was 
measured and then respiration was stimulated by the uncoupler FCCP 
(500 nM, C FCCP, V10 FCCP, V30 FCCP). * indicate significant dif-
ference (p < 0.05, n > 4) from the corresponding control measured in 
the absence of vinpocetine
Fig. 5  Effect of vinpocetine on  H2O2 production of synaptosomes. 
Synaptosomes were preincubated in glucose-containing standard 
medium for 5 min under control conditions  (C) or with vinpocetine 
(10 or 30 μM, hatched and cross hatched bars). Recording of baseline 
 H2O2 formation was started after addition of Amplex Ultrared and 
horseradish peroxidase. After 200 s rotenone (1 μM, gray bars) was 
given. *  indicate significant difference (p < 0.05, n > 4)  compared to 
the corresponding control measured in the absence of vinpocetine
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(not shown). Addition of oligomycin decreased the rate of 
respiration, but in the presence of vinpocetine the remaining 
respiration rate (leak respiration) was always higher than 
under control conditions, indicating the uncoupling effect 
of this vinca derivative.
Effects of Vinpocetine on  H2O2 Formation in Isolated 
Mitochondria
Usually there is a close correlation between the rate of oxi-
dation and  H2O2 production. The mitochondrial  H2O2 for-
mation has been investigated with glutamate plus malate 
and succinate substrates.
Using the complex I substrates glutamate plus malate, 
basal ROS production was only a fraction of that detected 
in succinate-supported mitochondria. This observation 
agrees with our and others previous studies [39, 40]. 
Vinpocetine also decreased the rate of  H2O2 formation 
in the presence of glutamate plus malate (Fig. 7). Stimu-
lation of respiration with ADP resulted in a decrease of 
ROS production irrespective of the presence or absence 
of vinpocetine. Inhibition of ATP synthesis with oligo-
mycin stimulated  H2O2 formation, and this increase was 
more modest (201% vs. 387%) in vinpocetine-treated 
mitochondria (Fig. 7a).
In succinate supported mitochondria ROS production 
was 2074 ± 282 pmol/min/mg protein. Under control con-
ditions ADP dramatically decreased ROS production by 
94.6% Vinpocetine added after succinate decreased  H2O2 
formation by 79.4%. Addition of the ATP synthesis inhibi-
tor oligomycin stimulated  H2O2 release by a factor of 22.2, 
while in the presence of vinpocetine only by a factor of 
only 6.1 (Fig. 3b).
ATP Synthesis in Mitochondria
The most important bioenergetic function of mitochon-
dria is ATP production. Alterations in state 3 respiration 
and membrane potential suggested a decreased capacity 
for ATP production. Measurement of ATP release from 
mitochondria in the presence of respiratory substrates and 
ADP provides information about this complex function.
Mitochondrial ATP synthesis was measured in gluta-
mate plus malate supported mitochondria. In the pres-
ence of glutamate plus malate vinpocetine evoked a 
dose-dependent inhibition of ATP synthesis (Fig. 8a). 
Applying 30 μM vinpocetine decreased ATP production 
by 17.9 ± 4.6%. Addition of oligomycin inhibited ATP pro-
duction by about 95% indicating that most of the ATP pro-
duction could be attributed to oxidative phosphorylation.
Fig. 6  Effects of vinpocetine on mitochondrial respiration. Mitochon-
dria supported by glutamate plus malate respiratory substrates (a) or 
by succinate (b) were incubated in standard mitochondrial medium. 
Vinpocetine (vinpo;  30  μM), ADP (2  mM) and oligomycin (oligo; 
5 μM) were added as indicated in the original traces of the inset. The 
effects of vinpocetine (gray bars) were compared to the control (white 
bars, vehicle treated). Data are % of mean control oxygen consump-
tion. Mean ± SE; n > 5; * significant difference from the correspond-
ing solvent controls
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ATPase Activity of Mitochondria
The formation of ATP by oxidative phosphorylation is influ-
enced by many factors, e.g. transport of respiratory sub-
strates, ADP, activity of respiratory complexes, activity of 
citric acid cycle enzymes. Therefore, for specific assessment 
of ATP synthase activity mitochondria were supported by 
ATP only and the rate of mitochondrial ADP release was 
measured. Mitochondria were incubated in the presence of 
vinpocetine (30 μM) or vehicle. In the presence of vinpoce-
tine the rate of ADP hydrolysis more than doubled (increased 
by 137%). The uncoupler FCCP stimulated ADP hydrolysis 
and mitigated the difference between the effect of vinpoce-
tine. In order to detect the maximal reverse activity of ATP 
synthase, mitochondria were permeabilized by the pore form-
ing alamethicin. Vinpocetine also stimulated ATP hydrolysis 
in fully permeabilized mitochondria (Fig. 8b).
Mitochondrial  Ca2+ Uptake and  Ca2+‑Induced  Ca2+ 
Release
Another function of mitochondria is  Ca2+-handling. To 
assess the  Ca2+ uptake capacity,  Ca2+ pulses (12.5 μM) were 
added and taken up by the mitochondria in 50 s intervals 
(Fig. 9a). The uptake was fast  (Vmax for the  Ca2+ uniporter 
was 1200 nmol  Ca2+/min/mg protein. After adding multiple 
 Ca2+ pulses, the  Ca2+ uptake capacity of mitochondria was 
gradually lost. When  Ca2+ uptake stopped, mitochondria 
started to release the previously accumulated Ca2+ due to 
the mPTP opening  (Ca2+-induced  Ca2+ release (mCICR)). 
In the presence of vinpocetine (30 μM), the maximal  Ca2+ 
uptake capacity of mitochondria remained unaltered, how-
ever the mCICR decreased.
Effect of Vinpocetine on  Ca2+‑Induced Swelling 
of Mitochondria
In the above mCICR assay, in parallel with  Ca2+ record-
ing, swelling of mitochondria was measured from the same 
samples (Fig. 9b). In the presence of vinpocetine (30 μM) 
mitochondrial swelling (an indicator of mPTP opening) was 
decreased, indicated by the smaller decrease in light scatter 
after the onset of mCICR.
Discussion
Vinpocetine was introduced to clinical therapy decades ago, 
and many possible molecules and structures were associated 
as targets for its beneficial effects. It is obvious that energy 
homeostasis is a crucial factor in the cell survival and can 
Fig. 7  Effects of vinpocetine on mitochondrial  H2O2 formation in 
glutamate plus malate (a) and succinate-supported (b) mitochondria. 
Mitochondria were incubated in the standard mitochondrial medium. 
Vinpocetine (vinpo; 30  μM), ADP (2  mM), oligomycin (oligo; 
5 μM), and FCCP (250 nM) were given as indicated in the insets. At 
the end of each measurement 100 pmol  H2O2 was added for calibra-
tion (cal). * indicates significant difference (p < 0.05, n > 4) from the 
corresponding vinpocetine-free controls
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also determine the type of cell death. Although the binding 
of vinpocetine to the mitochondrial peripheral benzodiaz-
epine receptor (PBR) has already been demonstrated [41, 
42], systematic mitochondrial studies have not followed this 
early observation.
In the present study, the bioenergetic aspects of the effects 
of vinpocetine were investigated on primary brain capillary 
endothelial cells, neurons, isolated nerve terminals (synap-
tosomes) and in isolated mitochondria.
Measurements in Cellular Systems
Ca2+ Transients in Primary Brain Capillary Endothelial Cells
Integrity of the blood brain barrier is an important factor in 
the maintenance of CNS homeostasis [43]. In brain capillary 
endothelial cells, purinergic signaling evoked cytoplasmic 
and mitochondrial  Ca2+ transients (Fig. 1). In the presence of 
vinpocetine the peak height of the  Ca2+ transient remained 
unaltered, however, the half decay time of the mitochon-
drial  Ca2+ transient was increased, thus  Ca2+ release was 
slower in the presence of vinpocetine (Fig. 2). The phenom-
enon may be attributed to inhibition of the mitochondrial 
 Na+/Ca2+ exchange, the major route of the mitochondrial 
 Ca2+ release [44]. This effect of vinpocetine is similar to that 
found with CGP-37157, a dedicated inhibitor of the mito-
chondrial  Na+-dependent  Ca2+ release [25]. CGP-37157 has 
neuroprotective effects [45]. Inhibition of ion channels is 
also in the spectrum of vinpocetine, e.g. it is an efficient 
blocker of the tetrodotoxin-sensitive voltage dependent  Na+ 
channel. Nevertheless, there are further alternative explana-
tions. Depolarization of mitochondria decreases the driving 
force of transport processes including the energy required 
for the forward operation of the  Na+/Ca2+ exchanger [46].
Fig. 8  Effects of vinpocetine on mitochondrial ATP synthesis (a) 
and ATPase activity (b). The rate of ATP synthesis in glutamate plus 
malate (G + M) supported mitochondria (0.5  mg/ml mitochondrial 
protein was measured in standard medium supplemented with the 
inhibitor of adenylate kinase, ADP (2 mM) in the presence (hatched 
bars on (a) and dotted line on the inset) or absence (white bars on (a), 
solid line on the inset) of vinpocetine. At 200 s G + M initiated oxi-
dative substrate-dependent ATP synthesis. Oligomycin (oligo; 5 μM) 
inhibited oxidative phosphorylation. ATPase activity (b) was meas-
ured on the basis of hydrolysis of exogenous ATP given to mitochon-
dria. ATP hydrolysis was measured under resting conditions (buffer), 
in the presence of uncoupler FCCP (250 nM) and in the presence of 
alamethicin, a pore-forming antibiotics. Vinpocetine (vinpo; 30 μM; 
gray bars). * indicates significant difference (p < 0.05, n > 4) from the 
corresponding vinpocetine-free controls (white bars)
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Delayed  Ca2+ Deregulation (DCD) in Cortical 
Neurons
DCD is a model of glutamate toxicity, where excessive 
 Ca2+ loads through  Ca2+ permeable glutamate channels 
could result in deterioration of calcium and energy homeo-
stasis. Vinpocetine did not affect DCD in primary cortical 
neurons. Our results somewhat differ from those published 
by others [12]. The reason of discrepancy is possibly attrib-
uted to the higher glutamate concentration applied in the 
present study (300 μM for 20 min vs. 25 μM for 30 min).
Measurements on Isolated Nerve Terminals 
(Synaptosomes)
Oxygen Consumption Measurements
Oxygen consumption of synaptosomes is attributed to the 
substrate oxidation of in situ mitochondria [47]. Thus, glu-
cose used as an energy supply for synaptosomes is metabo-
lised in glycolysis and subsequently in the mitochondria. 
Compromised mitochondrial  O2 consumption in synap-
tosomes energized by external glucose (Fig. 4) could be 
also explained by inhibition of either the glucose transport 
or glycolysis, besides mitochondrial effects. In order to rule 
out these possibilities, lactate was also used as respiratory 
substrate. Vinpocetine inhibited synaptosomal  O2 consump-
tion similarly in the presence of glucose or lactate, ruling out 
that this inhibition was be specific to the glucose metabo-
lism. These observations directed our attention towards iso-
lated mitochondria.
Release of  H2O2 from Synaptosomes
Vinpocetine inhibited  H2O2 formation in synaptosomes. 
Measurement of synaptosomal  H2O2 production using 
Amplex Ultrared dye and horseradish peroxidase gives 
indirect information about the ROS homeostasis. The infor-
mation are indirect, because (i) ROS sources other than 
mitochondria e.g. NADPH oxidases [47, 48], and nitrogen 
monoxide synthase (NOS) [49] can also be found in synap-
tosomes (ii) the cytoplasm possesses many enzymatic and 
nonenzymatic ROS scavenging systems [50, 51] and our 
detection system for  H2O2 is extra-synaptosomal; in syn-
aptosomes between the mitochondrial membranes and the 
plasma membrane of the synaptosomes both ROS generating 
and scavenging mechanisms can be found, therefore more 
direct information was acquired using isolated mitochondria.
Measurements in Isolated Guinea Pig Brain 
Mitochondria
Effect of Vinpocetine on Mitochondrial Membrane 
Potential, Oxygen Consumption and H2O2 Formation
In isolated mitochondria membrane potential was slightly 
depolarized (4.0 ± 0.6 mV) by vinpocetine. This together 
Fig. 9  Effect of vinpocetine on mitochondrial  Ca2+ handling. Effect 
of vinpocetine on the  Ca2+ uptake capacity and mCICR. a Rat brain 
mitochondria (0.05  mg/ml) were incubated in reaction medium. 
 CaCl2 pulses were added as indicated. The free  [Ca2+] of the medium 
was detected by Calcium-Green 5 N fluorescence in the absence (con-
trol) or in the presence of vinpocetine (vinpo, 30 μM) as indicated. 
The loss of  Ca2+ buffering capacity is followed by mCICR. Repre-
sentative traces n > 3. Calcium induced swelling of mitochondria (b). 
Swelling of mitochondrial matrix was measured simultaneously with 
 Ca2+ uptake by the light scattering method. More that  swelling and 
the loss of  Ca2+ buffering capacity were developed at the same time. 
Representative traces n > 3 from independent experiments
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with an increased respiration in the absence of ADP (Fig. 6) 
suggests an uncoupler-like effect that could be detected 
with both glutamate plus malate and succinate as respir-
atory substrates. In the absence of ADP (substrate only 
conditions) or in the presence of oligomycin the mitochon-
drial membrane potential is high and redox centers are very 
reduced. In this condition a high rate of  H2O2 production 
was detected both with complex I and complex II substrates 
(Fig. 7). Even slight depolarization could exponentially 
decrease the ROS formation under these conditions [40, 
52, 53]. Therefore, the ROS lowering effect of vinpocetine 
may be explained by mild uncoupling. The ADP stimulated 
respiration was strongly inhibited in the presence of vin-
pocetine. Like the depolarization in ADP-free conditions, 
the respiratory inhibition was also independent from what 
type of substrates (complex I or complex II) supported the 
mitochondria. This finding raises the possibility that either 
both complex I and II, or complex III, or complex IV or 
their combination were inhibited by vinpocetine.
ATP Synthetic and ATP Hydrolytic Rates in the Presence 
of Vinpocetine
Vinpocetine decreased the rate of ATP synthesis with glu-
tamate plus malate as respiratory substrates, but increased 
the rate of ATP hydrolysis in the absence of respiration-
supporting substrates. The concrete reasons behind a com-
promised mitochondrial ATP synthesis is generally rather 
obscure. In order to produce ATP efficiently, tens of mech-
anisms behind the four postulates of Mitchell should work 
perfectly and in synchrony. It is rather difficult to evalu-
ate our findings from the aspect of neuroprotection. The 
slight decrease in the rate of ATP synthesis in the pres-
ence of vinpocetine might be attributed to the uncoupling 
detected in  O2 consumption measurements. A less efficient 
ATP synthesis is not beneficial from the point of cell sur-
vival. On the other hand, an uncoupling-evoked decrease 
in membrane potential would decrease the rate of ROS 
production and could also accelerate ROS elimination by 
stimulating NADPH formation via the  NADP+-dependent 
isocitrate dehydrogenase or glutamate dehydrogenase. 
Therefore, this phenomenon might improve the redox 
homeostasis in mitochondria and the cell. The increased 
ATP hydrolysis rate suggests that vinpocetine does not 
inhibit the reverse mode of ATP synthase (and perhaps 
does not inhibit its forward mode, either).
Seeking the Mechanism and Conclusions
In the present paper, we attempted to describe the effects of 
vinpocetine on selected mitochondrial functions in light of 
the well documented beneficial effects of the drug on brain 
functions. Various findings presented above are somewhat 
controversial. Some of them may first seem to be nega-
tive, e.g. inhibition of mitochondrial respiration and ATP 
synthesis. Some of the effects are subjects of various inter-
pretations, e.g. mild uncoupling (its benefits are debated), 
the increased half time of  Ca2+ release from endothelial 
cells, the possible inhibition of the mitochondrial  Na+/Ca2+ 
exchanger, all may or may not have beneficial physiological 
effects. Finally, inhibition of the Ca2+-induced mitochondrial 
swelling, delayed CICR, and the very strong inhibition of the 
mitochondrial  H2O2 release are all unequivocally positive.
Considering that vinpocetine does not display any severe 
side effects, we may conclude that the positive effects dom-
inate under in vivo conditions. We also conclude that on 
the basis of the results presented above it is very likely that 
vinpocetine possesses more than one molecular target in 
mitochondria.
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